- Home
- FOXX vs JSPRW Comparison
FOXX vs JSPRW Comparison
Compare FOXX & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXX
- JSPRW
- Stock Information
- Founded
- FOXX 2017
- JSPRW N/A
- Country
- FOXX United States
- JSPRW United States
- Employees
- FOXX N/A
- JSPRW N/A
- Industry
- FOXX
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- FOXX
- JSPRW Health Care
- Exchange
- FOXX Nasdaq
- JSPRW Nasdaq
- Market Cap
- FOXX 33.5M
- JSPRW N/A
- IPO Year
- FOXX N/A
- JSPRW N/A
- Fundamental
- Price
- FOXX $4.65
- JSPRW $0.14
- Analyst Decision
- FOXX
- JSPRW
- Analyst Count
- FOXX 0
- JSPRW 0
- Target Price
- FOXX N/A
- JSPRW N/A
- AVG Volume (30 Days)
- FOXX 136.9K
- JSPRW 7.8K
- Earning Date
- FOXX 02-14-2025
- JSPRW 03-05-2025
- Dividend Yield
- FOXX N/A
- JSPRW N/A
- EPS Growth
- FOXX N/A
- JSPRW N/A
- EPS
- FOXX N/A
- JSPRW N/A
- Revenue
- FOXX $42,988,015.00
- JSPRW N/A
- Revenue This Year
- FOXX N/A
- JSPRW N/A
- Revenue Next Year
- FOXX N/A
- JSPRW N/A
- P/E Ratio
- FOXX N/A
- JSPRW N/A
- Revenue Growth
- FOXX 98.81
- JSPRW N/A
- 52 Week Low
- FOXX $2.45
- JSPRW $0.15
- 52 Week High
- FOXX $14.99
- JSPRW $0.16
- Technical
- Relative Strength Index (RSI)
- FOXX N/A
- JSPRW N/A
- Support Level
- FOXX N/A
- JSPRW N/A
- Resistance Level
- FOXX N/A
- JSPRW N/A
- Average True Range (ATR)
- FOXX 0.00
- JSPRW 0.00
- MACD
- FOXX 0.00
- JSPRW 0.00
- Stochastic Oscillator
- FOXX 0.00
- JSPRW 0.00
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.